These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26044287)

  • 1. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
    Ercolak V; Paydas S; Bagir E; Ergin M; Seydaoglu G; Celik H; Yavu B; Tanriverdi K; Gunaldi M; Afsar CU; Duman BB
    Acta Haematol; 2015; 134(4):199-207. PubMed ID: 26044287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
    Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
    Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma.
    Paydas S; Bağır E; Seydaoglu G; Ercolak V; Ergin M
    Ann Hematol; 2015 Sep; 94(9):1545-52. PubMed ID: 26004934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and prognostic and predictive relevance of PRAME in breast cancer.
    Doolan P; Clynes M; Kennedy S; Mehta JP; Crown J; O'Driscoll L
    Breast Cancer Res Treat; 2008 May; 109(2):359-65. PubMed ID: 17624586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
    Oberthuer A; Hero B; Spitz R; Berthold F; Fischer M
    Clin Cancer Res; 2004 Jul; 10(13):4307-13. PubMed ID: 15240516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia.
    Tajeddine N; Millard I; Gailly P; Gala JL
    Clin Chem Lab Med; 2006; 44(5):548-55. PubMed ID: 16681423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma.
    Qin Y; Lu J; Bao L; Zhu H; Li J; Li L; Lai Y; Shi H; Wang Y; Liu Y; Jiang B; Huang X
    Chin Med J (Engl); 2014; 127(9):1666-71. PubMed ID: 24791872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRAME gene expression profile in medulloblastoma.
    Vulcani-Freitas TM; Saba-Silva N; Cappellano A; Cavalheiro S; Toledo SR
    Arq Neuropsiquiatr; 2011 Feb; 69(1):9-12. PubMed ID: 21359415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
    Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
    Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
    Lerut E; Van Poppel H; Joniau S; Gruselle O; Coche T; Therasse P
    Int J Clin Exp Pathol; 2015; 8(8):9522-32. PubMed ID: 26464715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses.
    Winkler C; Steingrube DS; Altermann W; Schlaf G; Max D; Kewitz S; Emmer A; Kornhuber M; Banning-Eichenseer U; Staege MS
    Cancer Immunol Immunother; 2012 Oct; 61(10):1769-79. PubMed ID: 22419371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis.
    Zou C; Shen J; Tang Q; Yang Z; Yin J; Li Z; Xie X; Huang G; Lev D; Wang J
    Cancer; 2012 Apr; 118(7):1845-55. PubMed ID: 22009167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
    Abdelmalak CA; Yahya RS; Elghannam DM; El-Khadragy AE; Abd El Messih HM
    Clin Lab; 2014; 60(1):55-61. PubMed ID: 24600975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.